25.05
6.23%
1.47
After Hours:
25.05
Beam Therapeutics Inc Stock (BEAM) Forecast
The Beam Therapeutics Inc (BEAM) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $92.82, representing a +270.55% increase from the current price of $25.05. The highest analyst price target is $115.92, and the lowest is $69.72.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BEAM Price Target
Average 90.71
(+262.12% Upside)
Is Beam Therapeutics Inc (BEAM) A Buy Now?
Oscillators
Name | Value | Action |
---|---|---|
RSI(14) | 50.63 | Neutral |
STOCH(9,6) | 14.46 | Buy |
STOCHRSI(14) | 19.72 | Buy |
MACD(12,26) | 0.1806 | Sell |
ADX(14) | 21.45 | Neutral |
William %R | -66.85 | Neutral |
CCI(14) | -58.53 | Neutral |
Buy: 2
Sell: 1
Neutral: 4
Summary: Neutral
Moving Averages
Period | Simple | Exponential |
---|---|---|
MA10 |
25.87
Sell
|
25.04
Buy
|
MA20 |
24.93
Buy
|
24.97
Buy
|
MA50 |
24.51
Buy
|
24.79
Buy
|
MA100 |
25.33
Sell
|
25.07
Sell
|
MA200 |
26.75
Sell
|
25.43
Sell
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, BEAM could be considered a Potential Buy, with 17 technical analysis indicators signaling 7 Buy signals, 6 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on BEAM, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 50.63 indicates that BEAM is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 14.46 indicates that BEAM is oversold. This indicates that BEAM price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 19.72 indicates that BEAM is oversold. This suggests that BEAM price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 21.45 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -58.53 indicates that BEAM is still oversold but not to an extreme extent.
Long-term BEAM price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Beam Therapeutics Inc financial reports and earnings history, Beam Therapeutics Inc (BEAM) stock could reach $103.70 by 2030, $30.09 by 2040 and $4.6055 by 2050. See the projected annual prices until 2050 of the Beam Therapeutics Inc stock below:
- Beam Therapeutics Inc (BEAM) is expected to reach an average price of $18.61 in 2035, with a high prediction of $44.49 and a low estimate of $17.38. This indicates an $-25.72% rise from the last recorded price of $25.05.
- Beam Therapeutics Inc (BEAM) stock is projected to chart a bullish course in 2040, with an average price target of $22.67, representing an $-9.49% surge from its current level. The forecast ranges from a conservative $10.47 to a sky-high $30.09.
- Our analysts predict Beam Therapeutics Inc (BEAM) to jump -81.04% by 2045, soaring from $2.1436 to an average price of $4.75, potentially reaching $6.0212. While $2.1436 is the low estimate, the potential upside is significant.
- Beam Therapeutics Inc (BEAM) stock is expected to climb by 2050, reaching an average of $7.5455, a $-69.88% jump from its current level. However, a wide range of estimates exists, with high and low targets of $4.6055 and $5.8952, respectively, highlighting the market's uncertainty.
Beam Therapeutics Inc Stock (BEAM) Year by Year Forecast
Beam Therapeutics Inc Stock (BEAM) Price Forecast for 2024
Our forecast for BEAM stock price in 2024 now indicates an average price target of $63.79 with a high forecast of $115.92 and a low forecast of $11.67. The average prediction reflects an increase of +154.67% from the last recorded price of $25.05.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
December, 2024 | $89.56 | $69.72 | $115.92 | +257.51% |
Beam Therapeutics Inc Stock (BEAM) Price Forecast for 2025
Beam Therapeutics Inc Stock (BEAM) is expected to reach an average price of $90.71 in 2025, with a high prediction of $131.83 and a low estimate of $49.59. This indicates an +262.12% rise from the last recorded price of $25.05.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2025 | $65.76 | $56.03 | $120.04 | +162.53% |
February, 2025 | $73.24 | $63.76 | $93.18 | +192.36% |
March, 2025 | $70.00 | $59.49 | $79.94 | +179.43% |
April, 2025 | $71.50 | $49.59 | $79.27 | +185.41% |
May, 2025 | $87.15 | $67.56 | $87.90 | +247.89% |
June, 2025 | $81.34 | $75.94 | $131.83 | +224.70% |
July, 2025 | $95.32 | $75.71 | $104.97 | +280.50% |
August, 2025 | $102.34 | $93.30 | $110.31 | +308.53% |
September, 2025 | $79.71 | $77.56 | $103.23 | +218.20% |
October, 2025 | $83.00 | $74.23 | $91.44 | +231.33% |
November, 2025 | $72.65 | $68.84 | $93.54 | +190.01% |
December, 2025 | $73.23 | $58.53 | $81.71 | +192.32% |
Beam Therapeutics Inc Stock (BEAM) Price Forecast for 2026
The predicted value for Beam Therapeutics Inc (BEAM) in 2026 is set at an average of $48.82. Estimates vary from a peak of $76.16 to a trough of $21.48, indicating an +94.90% surge from the present price of $25.05.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2026 | $57.68 | $50.15 | $76.16 | +130.25% |
February, 2026 | $60.62 | $50.90 | $68.28 | +141.99% |
March, 2026 | $54.54 | $53.21 | $73.62 | +117.73% |
April, 2026 | $45.44 | $44.27 | $59.51 | +81.39% |
May, 2026 | $29.38 | $27.59 | $45.69 | +17.29% |
June, 2026 | $28.91 | $21.48 | $33.68 | +15.41% |
July, 2026 | $32.48 | $21.79 | $37.84 | +29.66% |
August, 2026 | $56.68 | $32.10 | $64.29 | +126.27% |
September, 2026 | $50.10 | $43.52 | $67.09 | +100.00% |
October, 2026 | $49.99 | $44.44 | $55.27 | +99.56% |
November, 2026 | $39.37 | $38.74 | $49.73 | +57.17% |
December, 2026 | $44.87 | $28.65 | $45.12 | +79.12% |
Beam Therapeutics Inc Stock (BEAM) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Beam Therapeutics Inc (BEAM) is $32.56, with a high forecast of $48.25 and a low forecast of $16.86. This indicates an +29.96% increase from the last price of $25.05.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2027 | $40.79 | $36.40 | $48.25 | +62.84% |
February, 2027 | $33.11 | $30.33 | $45.59 | +32.19% |
March, 2027 | $37.49 | $30.67 | $40.03 | +49.67% |
April, 2027 | $32.99 | $32.26 | $44.79 | +31.71% |
May, 2027 | $27.32 | $24.45 | $35.15 | +9.08% |
June, 2027 | $25.30 | $22.75 | $27.30 | +1.01% |
July, 2027 | $28.71 | $23.92 | $31.64 | +14.62% |
August, 2027 | $26.41 | $25.39 | $29.79 | +5.45% |
September, 2027 | $25.10 | $24.18 | $28.83 | +0.21% |
October, 2027 | $21.39 | $21.35 | $27.42 | -14.59% |
November, 2027 | $17.49 | $17.00 | $21.54 | -30.20% |
December, 2027 | $18.39 | $16.86 | $21.25 | -26.57% |
Beam Therapeutics Inc Stock (BEAM) Price Forecast for 2028
In 2028, Beam Therapeutics Inc (BEAM) is projected to reach an average price of $24.31, with a high projection of $44.04 and a low estimate of $4.5776. This indicates an -2.96% fall from the last price of $25.05.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2028 | $12.99 | $11.32 | $18.35 | -48.12% |
February, 2028 | $21.88 | $12.56 | $22.32 | -12.67% |
March, 2028 | $22.86 | $19.43 | $25.50 | -8.72% |
April, 2028 | $20.08 | $19.37 | $25.08 | -19.86% |
May, 2028 | $23.56 | $17.23 | $24.05 | -5.93% |
June, 2028 | $34.39 | $23.27 | $44.04 | +37.27% |
July, 2028 | $27.62 | $27.38 | $35.20 | +10.25% |
August, 2028 | $15.84 | $15.45 | $27.57 | -36.78% |
September, 2028 | $9.431 | $8.781 | $17.45 | -62.35% |
October, 2028 | $8.3131 | $4.5776 | $13.27 | -66.81% |
November, 2028 | $11.56 | $7.1375 | $13.28 | -53.85% |
December, 2028 | $8.2127 | $8.1027 | $15.87 | -67.21% |
Beam Therapeutics Inc Stock (BEAM) Price Forecast for 2029
The 2029 price forecast for Beam Therapeutics Inc Stock (BEAM) is $66.90 on average, with a high prediction of $125.15 and a low estimate of $8.6482. This represents an +167.05% increase from the previous price of $25.05.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2029 | $22.18 | $8.6482 | $24.92 | -11.46% |
February, 2029 | $36.11 | $19.21 | $36.35 | +44.16% |
March, 2029 | $74.01 | $37.05 | $86.82 | +195.47% |
April, 2029 | $85.75 | $62.83 | $109.03 | +242.30% |
May, 2029 | $75.44 | $64.55 | $113.18 | +201.17% |
June, 2029 | $67.71 | $49.20 | $86.36 | +170.28% |
July, 2029 | $59.13 | $52.71 | $73.15 | +136.04% |
August, 2029 | $59.14 | $42.84 | $70.80 | +136.07% |
September, 2029 | $71.58 | $58.78 | $79.33 | +185.74% |
October, 2029 | $74.67 | $69.27 | $125.15 | +198.07% |
November, 2029 | $87.74 | $69.06 | $98.33 | +250.25% |
December, 2029 | $99.30 | $81.01 | $103.28 | +296.41% |
Beam Therapeutics Inc Stock (BEAM) Price Forecast for 2030
Beam Therapeutics Inc Stock (BEAM) is expected to reach an average price of $59.45 in 2030, with a high forecast of $103.70 and a low forecast of $15.19. This signifies an +137.31% surge from the last price of $25.05.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2030 | $73.14 | $70.99 | $103.70 | +191.96% |
February, 2030 | $75.69 | $67.66 | $84.90 | +202.15% |
March, 2030 | $65.67 | $64.84 | $87.01 | +162.16% |
April, 2030 | $71.62 | $52.05 | $72.83 | +185.92% |
May, 2030 | $49.98 | $48.42 | $75.24 | +99.52% |
June, 2030 | $50.39 | $43.72 | $60.87 | +101.17% |
July, 2030 | $48.17 | $46.84 | $67.24 | +92.30% |
August, 2030 | $47.27 | $40.06 | $53.15 | +88.71% |
September, 2030 | $24.91 | $23.69 | $50.82 | -0.54% |
October, 2030 | $22.64 | $15.19 | $31.76 | -9.61% |
November, 2030 | $30.03 | $15.55 | $31.35 | +19.90% |
December, 2030 | $45.21 | $25.74 | $45.47 | +80.46% |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):